Background : The optimal duration of dual antiplatelet therapy (DAPT) following second-generation
drug-eluting stent (DES) implantation is still debated. Objectives : The aim of this …

Background Myocardial injury is frequent among patients hospitalized with coronavirus
disease-2019 (COVID-19) and is associated with a poor prognosis. However, the mechanisms of …

Background : Optimal upfront dual antiplatelet therapy (DAPT) duration after complex
percutaneous coronary intervention (PCI) with drug-eluting stents (DES) remains unclear. …

Background : Dual-antiplatelet therapy with aspirin and clopidogrel after percutaneous
coronary intervention reduces the risk for coronary thrombotic events (CTEs) at the expense of …

Background Whether the direct factor Xa inhibitor rivaroxaban can prevent thromboembolic
events after transcatheter aortic-valve replacement (TAVR) is unclear. Methods We randomly …

Although surgery was the mainstay of treatment for valvular heart disease, transcatheter
valve therapies have grown exponentially over the past decade. Two types of artificial heart …

… Gennaro Giustino … Mehran R., Giustino G. and Baber U. : "DAPT duration after DES: what
is the “mandatory” duration?". … Généreux and Giustino contributed equally to this work. …

Background : The optimal duration of dual antiplatelet therapy (DAPT) after drug-eluting
stent (DES) implantation is unclear, and its risks and benefits may vary according to DES …

The cardiovascular system is affected broadly by severe acute respiratory syndrome
coronavirus 2 infection. Both direct viral infection and indirect injury resulting from inflammation, …

Aortic stenosis (AS) is one of the most common valvular diseases encountered in clinical
practice. Current guidelines recommend aortic valve replacement (AVR) when the aortic valve …